Loading…
HealthEquity, Inc. is projected to rise to $102.70 by 2027, a +19% move from its current price of $86.56. HQY is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $85.10 | $86.59 | $88.10 | +0.03% |
| May 30 | $84.52 | $86.61 | $88.76 | +0.06% |
| May 31 | $84.08 | $86.64 | $89.28 | +0.09% |
| Jun 1 | $83.72 | $86.66 | $89.72 | +0.12% |
| Jun 2 | $83.40 | $86.69 | $90.11 | +0.15% |
| Jun 3 | $83.12 | $86.72 | $90.47 | +0.18% |
| Jun 4 | $82.86 | $86.74 | $90.81 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $82.86 | $86.74 | $90.81 | +0.21% |
| Week 2 | $81.47 | $86.93 | $92.74 | +0.42% |
| Week 3 | $80.47 | $87.11 | $94.30 | +0.64% |
| Week 4 | $79.65 | $87.29 | $95.67 | +0.85% |
| Week 5 | $78.96 | $87.48 | $96.91 | +1.06% |
| Week 6 | $78.36 | $87.66 | $98.07 | +1.27% |
| Week 7 | $77.82 | $87.85 | $99.16 | +1.49% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web-based tool.
The company also provides flexible spending accounts (FSA) for health and dependent care; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. In addition, the company offers HSA and FSA members with access to certain healthcare products, programs, and services through its marketplace.
It serves clients through a direct sales force; and brokers and advisors, a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.
HealthEquity, Inc. (HQY) operates in the Healthcare sector as a technology-enabled services provider focused on consumer-directed health accounts and related benefit programs. It currently trades at $88.11 per share with a market capitalization of $7.39B and holds a rank of 1086 among tracked assets.
The current price outlook is informed by a year-by-year forecast showing upside potential, with the 2026 average price at $88.11, a min of $73.21 and a max of $116.01, and bullish sentiment from 2027 onward.
By 2030 the forecast shows an average price of $172.62 with a max of $235.84 and a min of $134.61, and by 2050 the forecast shows an average price of $822.69 with a max of $1,346.25 and a min of $544.27, all accompanied by bullish sentiment in the longer horizon.
A major floor 15.4% below — a decisive break under it would weaken the trend.
The nearest floor, 10.2% below — buyers have tended to step in here.
Price is pressing into resistance (1.8% away) — a breakout level to watch.
A major ceiling 9.2% above — clearing it would confirm fresh momentum.
Key HQY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HQY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $87.18 | Sell | $86.55 | Buy |
| MA 10 | $85.03 | Buy | $85.56 | Buy |
| MA 20 | $83.76 | Buy | $84.42 | Buy |
| MA 50 | $82.89 | Buy | $83.33 | Buy |
| MA 100 | $82.51 | Buy | $84.35 | Buy |
| MA 200 | $88.45 | Sell | $87.04 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.63 | Neutral |
| Stoch RSI (14) | 70.65 | Neutral |
| CCI (20) | 96.71 | Neutral |
| Williams %R (14) | -20.26 | Info |
| MACD (12,26,9) | 0.47 | Buy |
| ROC (12) | 2.03 | Buy |
| Bollinger %B (20,2) | 0.81 | Neutral |
| Stochastic %K (14) | 79.74 | Neutral |
| TRIX (15) | 0.12 | Buy |
| Awesome (5,34) | 3.91 | Buy |
| Ultimate (7,14,28) | 65.94 | Neutral |
| Momentum (10) | 6.10 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 88.32 | Sell |
| ADX (14) | 11.16 | Neutral |
| ATR (14) | 1.31 | Info |
The 30-day technical picture is bullish, with RSI(14) at 60 and a price near key levels. The 50-day simple moving average is $82.54 and the 200-day simple moving average is $88.51, providing a baselined trend around the current price.
Support is identified at $77.75 and resistance at $88.11. The 30-day range spans from $78.15 to $99.34, indicating recent volatility around the current level of $88.11.
Annualized volatility stands at 30%, underscoring meaningful short-term price fluctuations around the near-term trend."
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $73.21 | $86.56 | $112.90 | 0% | Neutral | |
| $83.90 | $102.70 | $131.59 | +19% | Neutral | |
| $91.36 | $113.88 | $149.72 | +32% | Bullish | |
| $115.35 | $145.96 | $195.90 | +69% | Bullish | |
| $127.75 | $163.80 | $223.73 | +89% | Bullish | |
| $128.95 | $167.33 | $232.12 | +93% | Bullish | |
| $142.13 | $186.50 | $262.34 | +115% | Bullish | |
| $148.58 | $197.01 | $280.68 | +128% | Bullish | |
| $157.30 | $210.63 | $303.64 | +143% | Bullish | |
| $185.03 | $250.09 | $364.50 | +189% | Bullish | |
| $244.95 | $345.26 | $527.18 | +299% | Bullish | |
| $491.11 | $742.26 | $1,214.54 | +758% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $73.21 | $86.56 | $101.69 | +0.00% |
| June 2026 | $76.49 | $89.23 | $106.11 | +3.08% |
| July 2026 | $75.83 | $88.97 | $106.81 | -0.29% |
| August 2026 | $76.19 | $89.80 | $108.58 | +0.93% |
| September 2026 | $78.39 | $92.73 | $112.80 | +3.27% |
| October 2026 | $78.48 | $93.16 | $113.92 | +0.46% |
| November 2026 | $76.60 | $91.19 | $112.05 | -2.11% |
| December 2026 | $76.62 | $91.48 | $112.90 | +0.32% |
Click any year to see its month-by-month HQY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The HQY price prediction for 2026 points to an average of $86.56 (low $73.21, high $112.90) — a potential gain of 0% on today's $86.56. A consolidation phase looks the most probable path here.
In 2027, HQY is projected to trade between $83.90 and $131.59, averaging $102.70 — a potential gain of +19% from today's $86.56. That is up +19% on the projected 2026 average. Price action looks broadly range-bound.
HealthEquity, Inc.'s 2028 outlook centres on $113.88, within a $91.36 to $149.72 range. That is up +11% on the projected 2027 average. That marks a +32% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, HQY could reach as high as $195.90, with a base case around $145.96 and support toward $115.35 — roughly +69% from $86.56. Momentum favours further upside here.
Expect HQY to range from $127.75 to $223.73 through 2030. The $163.80 average target implies a +89% move from current prices. That is up +12% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The HQY price prediction for 2031 points to an average of $167.33 (low $128.95, high $232.12) — a potential gain of +93% on today's $86.56. Momentum favours further upside here.
In 2032, HQY is projected to trade between $142.13 and $262.34, averaging $186.50 — a potential gain of +115% from today's $86.56. That is up +11% on the projected 2031 average. Buyers look set to stay in control over this stretch.
HealthEquity, Inc.'s 2033 outlook centres on $197.01, within a $148.58 to $280.68 range. That is up +6% on the projected 2032 average. That marks a +128% change versus current levels. Momentum favours further upside here.
By 2034, HQY could reach as high as $303.64, with a base case around $210.63 and support toward $157.30 — roughly +143% from $86.56. Buyers look set to stay in control over this stretch.
Expect HQY to range from $185.03 to $364.50 through 2035. The $250.09 average target implies a +189% move from current prices. That is up +19% on the projected 2034 average. Momentum favours further upside here.
The HQY price prediction for 2040 points to an average of $345.26 (low $244.95, high $527.18) — a potential gain of +299% on today's $86.56. Buyers look set to stay in control over this stretch.
In 2050, HQY is projected to trade between $491.11 and $1,214.54, averaging $742.26 — a potential gain of +758% from today's $86.56. That is up +115% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in HQY today (≈ 11.55268 HQY) could be worth
$8,575.13
+$7,575.13 (+758%) by 2050 · US Dollar
Based on the average projected HQY price of $742.26 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HQYwould be worth at today's price.
$1,000 invested in HQY on May 27, 2025 (≈ 9.887285 HQY) would be worth
$855.84
-$144.16 (-14.4%) today · 0.86× · US Dollar
Based on a HQY entry price of $101.14 vs. today's $86.56.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $87.55 | $988.69 | -1.1% |
| 1 month ago | $83.52 | $1,036.4 | +3.6% |
| 3 months ago | $77.39 | $1,118.49 | +11.8% |
| 6 months ago | $105.18 | $822.97 | -17.7% |
| 1 year ago | $101.14 | $855.84 | -14.4% |
| All time (5.0y) ago | $83.33 | $1,038.76 | +3.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HQY forecast.
Our base-case forecast reaches $170.00 around 2032.
Implied market cap at $170.00: $14.25B
The multi-year forecast shows a bullish path from 2027 onward, with 2027’s average price at $106.19 and a max of $136.12 (ROI 20.5), followed by continued upside each year through 2034 and beyond. By 2030, the average is $172.62 with a max of $235.84 (ROI 95.9) and a bullish sentiment.
The long-run forecast strengthens further, with 2040 averaging $378.26 and a max of $577.63 (ROI 329.3), and 2050 averaging $822.69 with a max of $1,346.25 (ROI 833.7), both labeled bullish. These projections imply substantial upside across the horizon, but they remain estimates and depend on market conditions and execution.
Overall, the long-term outlook points to meaningful appreciation versus today’s level, yet investors should consider the inherent uncertainty and the possibility that outcomes may differ from the forecast."
Tap a question to reveal the answer.
2030 avg $172.62; min $134.61; max $235.84; ROI 95.9%; sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising averages and positive ROI through 2050, including 2030 avg $172.62; ROI 95.9% and 2050 avg $822.69; ROI 833.7%.
Yes. The 2026 max is $116.01, and the 2027 avg is $106.19, indicating the possibility of crossing $100 within the forecast window.
Current price $88.11; market cap $7.39B.
2050 min $544.27; avg $822.69; max $1,346.25; ROI 833.7%; sentiment BULLISH.
HealthEquity, Inc. Community Discussion
0Share your HealthEquity, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.